News

Smart Oxygen Solutions’ Supplemental Oxygen Delivery Device Supasses FDA Regulatory Pathway Milestone

ieCrowd™ recently announced the achievement of a crucial milestone in the commercial advancement of Smart Oxygen, the firm’s supplemental oxygen delivery device. The Smart Oxygen device is being advanced by ieCrowd’s subsidiary Smart Oxygen Solutions and has the ability to automatically adjust to the patient’s need for oxygen, even if those demands are constantly changing, through analyzing the level of…

COPD Symptom Tracking Through New Online Platform Shows Promising Results

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by progressive breathlessness, acute exacerbations, increased coughing, mucus, and a feeling of tightness in patients’ chest. Usually if the exacerbation symptoms are not detected and treated on time, they can escalate, leading to a more acute scenario, which can diminish…

Asthma Symptoms Found To Help Identify ACOS Patients

In a new study entitled “Defining the Asthma-COPD overlap syndrome in a COPD cohort,” authors show that using clinical asthma features is an effective diagnosis strategy to identify patients with asthma–chronic obstructive pulmonary disease (COPD) overlapping syndrome (ACOS). The study was published in the journal…

Screening For COPD in Asymptomatic Adults Not Recommended by USPSTF

Chronic Obstructive Pulmonary Disease (COPD) includes a group of progressive lung diseases such as emphysema, chronic bronchitis, non-reversible asthma, and some forms of bronchiectasis. COPD typically manifests itself in individuals who have had a long-term contact with harmful pollutants,a history of smoking, or who have a genetic predisposition to the disease. According to the…

Boehringer Releases Positive Update on OTEMTO Phase III Trial Findings Showing Superior Clinical Performance of Spiolto Respimat

Boehringer Ingelheim recently released a report on the company’s findings from the Phase IIIb OTEMTO 1 (NCT01964352) & 2 (NCT02006732) clinical trials, which are testing combination treatment Spiolto® Respimat® (tiotropium/olodaterol) for patients with chronic obstructive pulmonary disease (COPD). The update is published in the…